APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+7.12%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$3.58B
AUM Growth
+$3.58B
(+20%)
Cap. Flow
+$540M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
34.78%
Holding
131
New
36
Increased
33
Reduced
15
Closed
37
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$103M |
| 2 |
Medtronic
MDT
|
$85.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$80.2M |
| 4 |
Nuvation Bio
NUVB
|
$78.6M |
| 5 |
AbbVie
ABBV
|
$78M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$137M |
| 2 |
Quest Diagnostics
DGX
|
$94.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$87.1M |
| 4 |
Organogenesis Holdings
ORGO
|
$73.9M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$57.5M |
Sector Composition
| 1 | Healthcare | 96.26% |
| 2 | Financials | 0.29% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Intellia Therapeutics
NTLA
$1.26B
| – | – |
-303,000
| Closed | -$16.5M |
|
127
Ocular Therapeutix
OCUL
$2.25B
| – | – |
-250,000
| Closed | -$5.18M |
|
128
Olema Pharmaceuticals
OLMA
$432M
| – | – |
-270,000
| Closed | -$13M |
|
129
Outset Medical
OM
$245M
| – | – |
-100,000
| Closed | -$5.68M |
|
130
Phathom Pharmaceuticals
PHAT
$843M
| – | – |
-152,500
| Closed | -$5.07M |
|
131
Rocket Pharmaceuticals
RCKT
$358M
| – | – |
-50,000
| Closed | -$2.74M |
|